Loading...

AUTL AUTOLUS THERAPEUTICS PLC Management Changes 8-K Filing

TLS

TL

AUTOLUS THERAPEUTICS PLC

(AUTL)

2025 8-K

Financial Results Update

New Agreement Signed

Financial Update

Director Appointment

Financial Update

Annual Report and AGM Notice

Financial Statements

Investor Update

Management Changes

Financial Results

Corporate Update

Financial Results

Corporate Update

Management Change

Lease Amendment

Financial Results and Corpo...

Financial Statements and Ex...

Clinical Study Data Announc...

Financial Results and Corpo...

Rescheduled Conference Call...

Management Changes

Accounting Error

Conference Call Transcript

Financial Results and Manag...

Corporate Presentation

Underwriting Agreement

License and Option Agreemen...

FDA Accepts BLA for obecabt...

Appointment of New Director

Management Changes

ASH Annual Meeting Presenta...

Regulation FD Disclosure

External Links:

On November 12, 2025, Autolus Therapeutics plc reported its financial results for Q3 2025 and appointed Patrick McIlvenny as Principal Accounting Officer effective November 7, 2025. This event is significant and carries a neutral sentiment for investors.

AI Assistant

AUTOLUS THERAPEUTICS PLC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.